Purucker E, Winograd R, Roeb E, Matern S
Medizinische Klinik III, RWTH Aachen, Germany.
Res Exp Med (Berl). 1998 Dec;198(4):167-74. doi: 10.1007/s004330050100.
We do not know much about the changes that occur in reduced (GSH) and oxidized (GSSG) glutathione in the development of liver cirrhosis. Therefore, we investigated the glutathione redox system during development of liver cirrhosis after bile-duct ligation in rats. We compared the GSH and GSSG content of liver and plasma between bile-duct-ligated rats and sham-operated controls 6 and 24 h and 5, 15, 23, and 38 days after operation. Compared to controls (x +/- SD: 6.07 +/- 0.52 mumol/g wet wt.), liver GSH significantly increased 24 h (+ 37%) and 5 days (+ 53%) after bile-duct ligation. Thereafter, GSH continuously declined to 4.25 +/- 0.64 mumol/g (-31%; P < 0.001) at the end of the observation period after 38 days. The GSH turnover in 5-day bile-duct-ligated rats with high GSH concentrations was not significantly different than in sham-operated controls (16 nmol/min per g after bile-duct ligation and 15 nmol/min per g in controls). GSSG (211 +/- 42 nmol/g wet wt. in controls) was significantly lower 6 and 24 h after bile-duct ligation (-34% and -43%, respectively). Thereafter, GSSG increased and was about 100% higher than in controls after 23 and 38 days. The relation of GSSG to GSH in liver continuously increased from 3.4 to 20.5% after bile-duct ligation. The course of plasma GSH (9.57 +/- 0.79 mumol/l) paralleled hepatic GSH on a lower level: + 14% at day 5, -41% at day 15 and -51% at the end of the observation period. Plasma GSSG (0.99 +/- 0.31 mumol/l) was inversely related to liver GSSG: there were increased concentrations early after bile duct ligation (day 5: + 91%) and reduced concentrations (-44%) at the end of the observation period. Dynamic changes of the glutathione status occur in the development of liver cirrhosis after bile-duct ligation. These changes are consistent with increased oxidative stress in the liver and a deficit of transporting GSSG from the cells into plasma.
我们对肝硬化发展过程中还原型(GSH)和氧化型(GSSG)谷胱甘肽的变化了解不多。因此,我们研究了大鼠胆管结扎后肝硬化发展过程中的谷胱甘肽氧化还原系统。我们比较了胆管结扎大鼠与假手术对照组在术后6小时、24小时以及5天、15天、23天和38天肝脏和血浆中的GSH和GSSG含量。与对照组(x±SD:6.07±0.52 μmol/g湿重)相比,胆管结扎后24小时(增加37%)和5天(增加53%)肝脏GSH显著升高。此后,GSH持续下降,在38天观察期结束时降至4.25±0.64 μmol/g(降低31%;P<0.001)。GSH浓度高的5天胆管结扎大鼠的GSH周转率与假手术对照组无显著差异(胆管结扎后为16 nmol/min per g,对照组为15 nmol/min per g)。GSSG(对照组为211±42 nmol/g湿重)在胆管结扎后6小时和24小时显著降低(分别降低34%和43%)。此后,GSSG升高,在23天和38天后比对照组高约100%。胆管结扎后肝脏中GSSG与GSH的比值从3.4%持续增加到2。5%。血浆GSH(9.57±0.79 μmol/l)的变化过程与肝脏GSH平行,但处于较低水平:第5天增加14%,第15天降低41%,观察期结束时降低51%。血浆GSSG(0.99±0.31 μmol/l)与肝脏GSSG呈负相关:胆管结扎后早期(第5天:增加91%)浓度升高,观察期结束时浓度降低(降低44%)。胆管结扎后肝硬化发展过程中谷胱甘肽状态发生动态变化。这些变化与肝脏氧化应激增加以及细胞内GSSG向血浆转运不足一致。